New York, March 3, 2026, 14:04 ET — Regular session
UnitedHealth Group Incorporated (UNH) shares fell 2.1% to $288.79 in afternoon trading on Tuesday, after touching a session low of $284.63. The drop tracked declines across major U.S. health insurers, with Elevance Health down about 2.1%, Humana off 2.9% and Cigna down 2.7%.
The selling landed on a rough day for equities, with Wall Street’s main indexes sliding as investors weighed the inflation impact of a widening Middle East conflict and higher energy costs. “Investors worry about additional inflation coming down the road,” Robert Pavlik, senior portfolio manager at Dakota Wealth, said. 1
Health insurers have another worry sitting closer to home: regulators. The Centers for Medicare & Medicaid Services told Elevance it intends to impose sanctions that would suspend enrollment in the insurer’s Medicare Advantage prescription drug plans unless CMS determines deficiencies have been addressed, Reuters reported on Monday. 2
Risk adjustment — a payment model that pays insurers more when members are sicker, based in part on diagnosis codes — sits at the center of that dispute. Barclays analyst Andrew Mok said an intra-year enrollment pause is unlikely to be material for earnings, but “is a negative regulatory signal” as CMS expands its data validation audits. 2
UnitedHealth itself filed a new automatic shelf registration on Monday, giving it flexibility to sell debt and other securities from time to time, a filing showed. The company also filed its annual report on Form 10-K for the year ended Dec. 31, 2025, and disclosed a chief accounting officer change effective March 2. 3
In the 8-K, UnitedHealth said Dennis Stankiewicz was appointed chief accounting officer, while Tom Roos will transition from that role to become chief financial officer of Optum Insight. 4
A shelf registration is routine for large issuers. It is essentially a ready-to-use framework for future fund-raising; it does not, by itself, mean an offering is imminent.
The filings arrive as investors remain sensitive to how Medicare Advantage funding and oversight could reshape earnings power across the managed-care group. UnitedHealth in late January warned 2026 revenue would decline for the first time since 1989 after the government proposed a near-flat 2027 Medicare Advantage rate increase, and CEO Stephen Hemsley said the company was returning to “financial rigor,” according to Reuters. 5
But plenty can still go sideways. If the energy shock keeps inflation hotter and yields higher, even defensive corners of the market can take hits. And if CMS widens enforcement on risk-adjustment submissions beyond Elevance, headline risk could become a feature for the whole sector.
Traders are now watching the March 10 deadline for Elevance’s written rebuttal and the March 31 start date for any enrollment suspension, which could set the tone for how aggressively regulators lean into Medicare Advantage oversight. 6
